ArticleMedical oncology (Northwood, London, England)2012

BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?

Franz X Gruber et al.PubMed ↗Publisher ↗

No numbers read from the abstract.